Package Leaflet: Information for the User
Exelon 1.5 mg hard capsules
Exelon 3.0 mg hard capsules
Exelon 4.5 mg hard capsules
Exelon 6.0 mg hard capsules
rivastigmine
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
The active substance of Exelon is rivastigmine.
Rivastigmine belongs to a group of substances called cholinesterase inhibitors. In patients with Alzheimer's dementia or dementia associated with Parkinson's disease, certain nerve cells die in the brain, causing low levels of the neurotransmitter acetylcholine (a substance that allows nerve cells to communicate with each other). Rivastigmine acts by blocking the enzymes that break down acetylcholine: acetylcholinesterase and butyrylcholinesterase. By blocking these enzymes, Exelon allows the increase of acetylcholine in the brain, helping to reduce the symptoms of Alzheimer's disease and dementia associated with Parkinson's disease.
Exelon is used for the treatment of adult patients with mild to moderately severe Alzheimer's dementia, a progressive brain disorder that gradually affects memory, intellectual ability, and behavior. The capsules and oral solution can also be used for the treatment of dementia in adult patients with Parkinson's disease.
Do not take Exelon
If you are in one of these situations, inform your doctor and do not take Exelon.
Warnings and precautions
Consult your doctor before starting to take Exelon:
If you are in one of these situations, your doctor may consider it necessary to monitor you more closely while you are being treated.
If you have not taken Exelon for more than three days, do not take the next dose until you have consulted your doctor.
Children and adolescents
Exelon should not be used in the pediatric population for the treatment of Alzheimer's disease.
Other medicines and Exelon
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Exelon should not be administered at the same time as other medicines with similar effects to those of Exelon. Exelon may interfere with anticholinergic medicines (used to relieve stomach cramps or spasms, for the treatment of Parkinson's disease, or to prevent travel sickness).
Exelon should not be administered at the same time as metoclopramide (a medicine used to relieve or prevent nausea and vomiting). Taking the two medicines together may cause problems such as stiffness in the limbs and hand tremors.
In case you need to undergo surgery while taking Exelon, inform your doctor before you are given any anesthetic, as Exelon may exaggerate the effects of some muscle relaxants during anesthesia.
Caution should be exercised when using Exelon with beta-blockers (medicines such as atenolol used to treat hypertension, angina, and other heart conditions). Taking the two medicines together may cause complications such as a decrease in heart rate (bradycardia) that can lead to fainting or loss of consciousness.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
If you are pregnant, it is necessary to evaluate the benefits of using Exelon against the possible adverse effects for the fetus. Exelon should not be used during pregnancy unless clearly necessary.
You should not breastfeed while taking Exelon.
Driving and using machines
Your doctor will inform you if your illness allows you to drive or use machinery safely. Exelon may cause dizziness and somnolence, mainly at the start of treatment or when the dose is increased. If you feel dizzy or drowsy, do not drive or use machinery or perform other tasks that require your attention.
Follow exactly the administration instructions of this medicine indicated by your doctor. In case of doubt, consult your doctor, pharmacist, or nurse again.
How to start treatment
Your doctor will regularly check if the medicine is working for you. Your doctor will also check your weight while you are taking this medicine.
If you have not taken Exelon for more than three days, do not take the next dose until you have consulted your doctor.
Taking this medicine
If you take more Exelon than you should
If you accidentally take more Exelon than you should, inform your doctor. You may need medical attention. Some people who have accidentally taken higher doses have suffered from a feeling of dizziness (nausea), vomiting, diarrhea, high blood pressure, and hallucinations. There may also be a slowing of the heart rate and fainting.
If you forget to take Exelon
If you forget your dose of Exelon, wait and take the next dose at the usual time. Do not take a double dose to make up for forgotten doses.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
You may have side effects more frequently when you start your treatment or when your dose is increased. Generally, side effects will slowly disappear as your body gets used to the medicine.
Very common(may affect more than 1 in 10 people)
Common(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
Very rare(may affect up to 1 in 10,000 people)
Not known(cannot be estimated from the available data)
Patients with dementia or Parkinson's disease
These patients experience some side effects more frequently and also have some additional side effects:
Very common(may affect more than 1 in 10 people)
Common(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Other side effects observed in Exelon transdermal patches and that may appear with hard capsules:
Common(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Not known(cannot be estimated from the available data)
Reporting of side effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if it is possible side effects not listed in this leaflet. You can also report side effects directly through the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.
Exelon Composition
Each Exelon 1.5 mg capsule contains 1.5 mg of rivastigmine.
Each Exelon 3.0 mg capsule contains 3.0 mg of rivastigmine.
Each Exelon 4.5 mg capsule contains 4.5 mg of rivastigmine.
Each Exelon 6.0 mg capsule contains 6.0 mg of rivastigmine.
Product Appearance and Container Content
It is packaged in blisters and is available in three different presentations (28, 56 or 112 capsules), it is possible that not all are available in your country.
Marketing Authorization Holder
Novartis Europharm Limited
Vista Building
Elm Park, Merrion Road
Dublin 4
Ireland
Manufacturer
Novartis Farmacéutica, S.A.
Gran Via de les Corts Catalanes, 764
08013 Barcelona
Spain
Novartis Pharma GmbH
Roonstraße 25
D-90429 Nürnberg
Germany
You can request more information about this medication by contacting the local representative of the marketing authorization holder:
Belgium Novartis Pharma N.V. Tel: +32 2 246 16 11 | Lithuania SIA Novartis Baltics Lietuvos filialas Tel: +370 5 269 16 50 |
Novartis Bulgaria EOOD Tel: +359 2 489 98 28 | Luxembourg Novartis Pharma N.V. Tel: +32 2 246 16 11 |
Czech Republic Novartis s.r.o. Tel: +420 225 775 111 | Hungary Novartis Hungária Kft. Tel: +36 1 457 65 00 |
Denmark Novartis Healthcare A/S Tel: +45 39 16 84 00 | Malta Novartis Pharma Services Inc. Tel: +356 2122 2872 |
Germany Novartis Pharma GmbH Tel: +49 911 273 0 | Netherlands Novartis Pharma B.V. Tel: +31 88 04 52 111 |
Estonia SIA Novartis Baltics Eesti filiaal Tel: +372 66 30 810 | Norway Novartis Norge AS Tel: +47 23 05 20 00 |
Greece Novartis (Hellas) A.E.B.E. Tel: +30 210 281 17 12 | Austria Novartis Pharma GmbH Tel: +43 1 86 6570 |
Spain Novartis Farmacéutica, S.A. Tel: +34 93 306 42 00 | Poland Novartis Poland Sp. z o.o. Tel: +48 22 375 4888 |
France Novartis Pharma S.A.S. Tel: +33 1 55 47 66 00 | Portugal Novartis Farma - Produtos Farmacêuticos, S.A. Tel: +351 21 000 8600 |
Croatia Novartis Hrvatska d.o.o. Tel: +385 1 6274 220 | Romania Novartis Pharma Services Romania SRL Tel: +40 21 31299 01 |
Ireland Novartis Ireland Limited Tel: +353 1 260 12 55 | Slovenia Novartis Pharma Services Inc. Tel: +386 1 300 75 50 |
Iceland Vistor hf. Tel: +354 535 7000 | Slovakia Novartis Slovakia s.r.o. Tel: +421 2 5542 5439 |
Italy Novartis Farma S.p.A. Tel: +39 02 96 54 1 | Finland Novartis Finland Oy Tel: +358 (0)10 6133 200 |
Cyprus Novartis Pharma Services Inc. Tel: +357 22 690 690 | Sweden Novartis Sverige AB Tel: +46 8 732 32 00 |
Latvia SIA Novartis Baltics Tel: +371 67 887 070 | United Kingdom (Northern Ireland) Novartis Ireland Limited Tel: +44 1276 698370 |
Date of Last Revision of this Leaflet:
Other Sources of Information
Detailed information on this medication is available on the European Medicines Agency website: http://www.ema.europa.eu